rs28591989
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001177316.2(SLC34A3):c.*14A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.408 in 1,534,196 control chromosomes in the GnomAD database, including 129,849 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001177316.2 3_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC34A3 | ENST00000673835.1 | c.*14A>C | 3_prime_UTR_variant | Exon 13 of 13 | NM_001177316.2 | ENSP00000501114.1 | ||||
SLC34A3 | ENST00000361134.2 | c.*14A>C | 3_prime_UTR_variant | Exon 13 of 13 | 2 | ENSP00000355353.2 | ||||
SLC34A3 | ENST00000538474.5 | c.*14A>C | 3_prime_UTR_variant | Exon 13 of 13 | 5 | ENSP00000442397.1 |
Frequencies
GnomAD3 genomes AF: 0.396 AC: 60144AN: 151946Hom.: 12178 Cov.: 33
GnomAD3 exomes AF: 0.380 AC: 54111AN: 142348Hom.: 10770 AF XY: 0.377 AC XY: 28701AN XY: 76218
GnomAD4 exome AF: 0.409 AC: 565204AN: 1382132Hom.: 117661 Cov.: 35 AF XY: 0.408 AC XY: 278301AN XY: 682268
GnomAD4 genome AF: 0.396 AC: 60176AN: 152064Hom.: 12188 Cov.: 33 AF XY: 0.386 AC XY: 28722AN XY: 74360
ClinVar
Submissions by phenotype
not specified Benign:3
- -
- -
- -
not provided Benign:3
- -
Variant summary: The SLC34A3 c.*14A>C variant is located in the 3' UTR at a non-conserved nucleotide. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 7130/17986 (1/2, 1453 homozygotes), which significantly exceeds the estimated maximal expected allele frequency for a pathogenic SLC34A3 variant of 1/894. A reputable clinical laboratory cites the variant as benign. Therefore, taking all available lines of evidence into consideration, the variant of interest is classifed as Benign. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at